-
The dance floor at my daughter’s wedding had room for all
I’m officially a mother-in-law! That’s a new title for me. I’m a mom to the
-
Avidity Biosciences Announces Positive AOC 1044 Data
Avidity Biosciences, which received early funding from CureDuchenne, announced positive initial data from their EXPLORE44
-
WATCH: Edgewise Therapeutics – Clinical Trials in Becker Muscular Dystrophy (Webinar)
Edgewise Therapeutics recently joined PPMD for a webinar to provide the Becker community information about
-
Your Citizen Science At Work
By sharing your anonymous data through The Duchenne Registry, you are strengthening the power of
-
Phase 1/2 update ‘encouraging’ for DMD gene therapy RGX-202
The experimental gene therapy RGX-202 has been found to be well tolerated at a high
-
I’m at a crossroads in life, once again
Starting last week, I’ve been trying to get my life back on track after enduring
-
PGN-ED051, skipping exon 51, showing benefits in Phase 2 trial
A low dose of PGN-ED051, PepGen’s investigational exon 51-skipping therapy, safely increased dystrophin protein levels
-
Clinical Trials & Outcome Measures in Duchenne
Clinical trials and research studies are vitally important to improving health and quality of life
-
Ladies Luncheon Returns to Austin Country Club on September 26 for an “Afternoon in NYC” Benefiting CureDuchenne
Annual Event Features an Afternoon of Fashion and Fun to Raise Funds to Help Find
